These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27184938)

  • 1. Determination of the optimal sample size for a clinical trial accounting for the population size.
    Stallard N; Miller F; Day S; Hee SW; Madan J; Zohar S; Posch M
    Biom J; 2017 Jul; 59(4):609-625. PubMed ID: 27184938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal sample size determination for single-arm trials in pediatric and rare populations with Bayesian borrowing.
    Ji Z; Lin J; Lin J
    J Biopharm Stat; 2022 Jul; 32(4):529-546. PubMed ID: 35604836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian techniques for sample size determination in clinical trials: a short review.
    Pezeshk H
    Stat Methods Med Res; 2003 Dec; 12(6):489-504. PubMed ID: 14653352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of information methods to design a clinical trial in a small population to optimise a health economic utility function.
    Pearce M; Hee SW; Madan J; Posch M; Day S; Miller F; Zohar S; Stallard N
    BMC Med Res Methodol; 2018 Feb; 18(1):20. PubMed ID: 29422021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ; Lipsky AM; Berry DA
    Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian sample-size determination for two independent Poisson rates.
    Hand AL; Stamey JD; Young DM
    Comput Methods Programs Biomed; 2011 Nov; 104(2):271-7. PubMed ID: 21146897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A decision theoretic approach to sample size determination in clinical trials.
    Gittins JC; Pezeshk H
    J Biopharm Stat; 2002 Nov; 12(4):535-51. PubMed ID: 12477073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The choice of sample size: a mixed Bayesian / frequentist approach.
    Pezeshk H; Nematollahi N; Maroufy V; Gittins J
    Stat Methods Med Res; 2009 Apr; 18(2):183-94. PubMed ID: 18445695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A behavioural Bayes approach to the determination of sample size for clinical trials considering efficacy and safety: imbalanced sample size in treatment groups.
    Kikuchi T; Gittins J
    Stat Methods Med Res; 2011 Aug; 20(4):389-400. PubMed ID: 20223784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of information and optimal clinical trial design.
    Willan AR; Pinto EM
    Stat Med; 2005 Jun; 24(12):1791-806. PubMed ID: 15806619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exact sample size determination for a single Poisson random sample.
    Gentile S; Sambucini V
    Biom J; 2023 Oct; 65(7):e2200183. PubMed ID: 37160700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian sample size calculation for estimation of the difference between two binomial proportions.
    Pezeshk H; Nematollahi N; Maroufy V; Marriott P; Gittins J
    Stat Methods Med Res; 2013 Dec; 22(6):598-611. PubMed ID: 21436190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robust Bayesian sample size determination in clinical trials.
    Brutti P; De Santis F; Gubbiotti S
    Stat Med; 2008 Jun; 27(13):2290-306. PubMed ID: 18205170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian sample size for exploratory clinical trials incorporating historical data.
    Whitehead J; Valdés-Márquez E; Johnson P; Graham G
    Stat Med; 2008 Jun; 27(13):2307-27. PubMed ID: 18069728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Bayesian cost-benefit approach to the determination of sample size in clinical trials.
    Kikuchi T; Pezeshk H; Gittins J
    Stat Med; 2008 Jan; 27(1):68-82. PubMed ID: 17566967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian decision sequential analysis with survival endpoint in phase II clinical trials.
    Zhao L; Woodworth G
    Stat Med; 2009 Apr; 28(9):1339-52. PubMed ID: 19226557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian design for two-arm randomized Phase II clinical trials with endpoints from the exponential family using multiple constraints.
    Jiang W; Wick JA; He J; Mahnken JD; Mayo MS
    J Biopharm Stat; 2018; 28(5):824-839. PubMed ID: 29172970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Bayesian predictive sample size selection design for single-arm exploratory clinical trials.
    Teramukai S; Daimon T; Zohar S
    Stat Med; 2012 Dec; 31(30):4243-54. PubMed ID: 22807115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sample size calculations for comparative clinical trials with over-dispersed Poisson process data.
    Matsui S
    Stat Med; 2005 May; 24(9):1339-56. PubMed ID: 15568188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sample size estimation in single-arm clinical trials with multiple testing under frequentist and Bayesian approaches.
    Zaslavsky BG; Scott J
    J Biopharm Stat; 2012; 22(4):819-35. PubMed ID: 22651117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.